* Mesa Laboratories Inc MLAB.OQ reported quarterly
adjusted
earnings of 84 cents per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -10 cents. The mean expectation of
three analysts for the quarter was for earnings of 44 cents per
share. Wall Street expected results to range from -17 cents
to $1.55 per share.
* Revenue rose 14.9% to $58.17 million from a year ago;
analysts
expected $55.75 million.
* Mesa Laboratories Inc's reported EPS for the quarter was
62
cents.
* The company reported quarterly net income of $3.39
million.
* Mesa Laboratories Inc shares had risen by 23.2% this
quarter and
gained 2.0% so far this year.
FORECAST CHANGES
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Mesa Laboratories
Inc is $118.00
This summary was machine generated from LSEG data August 5 at
01:30 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.44 0.84 Beat
Mar. 31 2024 -0.11 3.70 Beat
Dec. 31 2023 0.19 0.39 Beat
Sep. 30 2023 0.16 -0.23 Missed